We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
Hemanext gets CE mark for RBC processing and storage system
Hemanext ONE is beneficial for people with sickle cell disease (SCD), thalassaemia, and myelodysplastic syndromes (MDS). (Credit: Crystal Blair from Pixabay)